These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 24298979)
21. The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation. Gyurko R; Van Dyke TE Crit Rev Immunol; 2014; 34(4):347-57. PubMed ID: 24941160 [TBL] [Abstract][Full Text] [Related]
22. Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. Pohl R; Rein-Fischboeck L; Meier EM; Eisinger K; Krautbauer S; Buechler C Exp Mol Pathol; 2015 Apr; 98(2):295-9. PubMed ID: 25681756 [TBL] [Abstract][Full Text] [Related]
23. Identification of endogenous resolvin E1 and other lipid mediators derived from eicosapentaenoic acid via electrospray low-energy tandem mass spectrometry: spectra and fragmentation mechanisms. Lu Y; Hong S; Yang R; Uddin J; Gotlinger KH; Petasis NA; Serhan CN Rapid Commun Mass Spectrom; 2007; 21(1):7-22. PubMed ID: 17131464 [TBL] [Abstract][Full Text] [Related]
24. Resolvin E1 Improves Mitochondrial Function in Human Alveolar Epithelial Cells during Severe Inflammation. Mayer K; Sommer N; Hache K; Hecker A; Reiche S; Schneck E; Weissmann N; Seeger W; Hecker M Lipids; 2019 Jan; 54(1):53-65. PubMed ID: 30697748 [TBL] [Abstract][Full Text] [Related]
25. A unique radioprotective effect of resolvin E1 reduces irradiation-induced damage to the inner ear by inhibiting the inflammatory response. Zhang J; Xu A; Niu T; Liu C; Zhang Y; Li T; Wang J; Wang Y; Sun D Radiat Oncol; 2020 Sep; 15(1):223. PubMed ID: 32977807 [TBL] [Abstract][Full Text] [Related]
26. RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. Hasturk H; Kantarci A; Ohira T; Arita M; Ebrahimi N; Chiang N; Petasis NA; Levy BD; Serhan CN; Van Dyke TE FASEB J; 2006 Feb; 20(2):401-3. PubMed ID: 16373400 [TBL] [Abstract][Full Text] [Related]
27. The effect of capsaicin on substance P expression in pulp tissue inflammation. Caviedes-Bucheli J; Azuero-Holguin MM; Munoz HR Int Endod J; 2005 Jan; 38(1):30-3. PubMed ID: 15606820 [TBL] [Abstract][Full Text] [Related]
28. Combination of resolvin E1 and lipoxin A4 promotes the resolution of pulpitis by inhibiting NF-κB activation through upregulating sirtuin 7 in dental pulp fibroblasts. Liu X; Wang C; Pang L; Pan L; Zhang Q Cell Prolif; 2022 May; 55(5):e13227. PubMed ID: 35411569 [TBL] [Abstract][Full Text] [Related]
29. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice. Kim TH; Kim GD; Jin YH; Park YS; Park CS Int Immunopharmacol; 2012 Dec; 14(4):384-91. PubMed ID: 22951188 [TBL] [Abstract][Full Text] [Related]
30. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. Hasturk H; Kantarci A; Goguet-Surmenian E; Blackwood A; Andry C; Serhan CN; Van Dyke TE J Immunol; 2007 Nov; 179(10):7021-9. PubMed ID: 17982093 [TBL] [Abstract][Full Text] [Related]
31. Treatment of exposed vital pulps with a corticosteroid antibiotic agent. Cowan A Br Dent J; 1966 Jun; 120(11):521-32. PubMed ID: 5327095 [No Abstract] [Full Text] [Related]
32. Impact of resolvin E1 on murine neutrophil phagocytosis in type 2 diabetes. Herrera BS; Hasturk H; Kantarci A; Freire MO; Nguyen O; Kansal S; Van Dyke TE Infect Immun; 2015 Feb; 83(2):792-801. PubMed ID: 25486994 [TBL] [Abstract][Full Text] [Related]
33. Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. Arita M; Oh SF; Chonan T; Hong S; Elangovan S; Sun YP; Uddin J; Petasis NA; Serhan CN J Biol Chem; 2006 Aug; 281(32):22847-54. PubMed ID: 16757471 [TBL] [Abstract][Full Text] [Related]
34. Immunolocalization of fibronectin during reparative dentinogenesis in rat molor teeth after pulp capping with mineral trioxide aggregate or calcium hydroxide. Bal C; Oztas N; Cincik M; Baris E N Y State Dent J; 2011 Nov; 77(6):36-42. PubMed ID: 22338817 [TBL] [Abstract][Full Text] [Related]
35. [The use of corticosteroid-antibiotic combinations during endodontic therapy]. Holland R; de Souza V; Nery MJ; Bernabé PF; de Mello W; Otoboni Filho JA Rev Paul Endodontia; 1980; 1(2):4-7. PubMed ID: 6934581 [No Abstract] [Full Text] [Related]
36. [Behavior of the dental pulp after pulpotomy and topical applications of drugs used in conservative therapy]. Holland R; Souza V; Milanezi LA; Mello W Rev Bras Odontol; 1971; 28(167):33-6. PubMed ID: 5279598 [No Abstract] [Full Text] [Related]
37. Immune cell profile of dental pulp tissue treated with zoledronic acid. de Barros Silva PG; Verde MEQL; Brizeno LAC; Wong DVT; Lima Júnior RCP; Sousa FB; Mota MRL; Alves APNN Int Endod J; 2017 Nov; 50(11):1067-1076. PubMed ID: 27977859 [TBL] [Abstract][Full Text] [Related]
38. A comparative study of dental pulp response to several pulpotomy agents. Tabarsi B; Parirokh M; Eghbal MJ; Haghdoost AA; Torabzadeh H; Asgary S Int Endod J; 2010 Jul; 43(7):565-71. PubMed ID: 20456516 [TBL] [Abstract][Full Text] [Related]
39. Resolvin E1: a novel lipid mediator in the resolution of allergic airway inflammation. Ishizuka T; Hisada T; Aoki H; Mori M Expert Rev Clin Immunol; 2008 Nov; 4(6):669-72. PubMed ID: 20477116 [TBL] [Abstract][Full Text] [Related]
40. Histopathologic study on pulp response to single-bottle and self-etching adhesive systems. Medina VO; Shinkai K; Shirono M; Tanaka N; Katoh Y Oper Dent; 2002; 27(4):330-42. PubMed ID: 12120769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]